Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06026345 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Affera Global Registry

StatusRecruiting
PhaseNot specified
Started2023-12-22
View on ClinicalTrials.gov ↗
The Affera Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to describe clinical performance and safety data in a broad patient population treated with the Affera Platform.

Amendment record

Amended 5 times since 2023-09-06; most recent filed 2025-10-02. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-31.

2025-10-02
Amendment Study Status, Contacts/Locations v5
2025-03-28
Amendment Study Status, Oversight, Contacts/Locations, IPDSharing v4
2025-02-11
Amendment Study Identification, Study Status, Sponsor/Collaborators, Oversight, Contacts/Locations v3
2024-08-05
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
2023-10-28
Amendment Study Status v1
2023-09-06
Original filing
Trial Details
NCT Number NCT06026345
Lead Sponsor Medtronic Cardiac Ablation Solutions
Conditions Atrial Fibrillation
Enrollment 540 participants
Start Date 2023-12-22
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-07